- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE Healthcare's 3-T Wide Bore MR System Receives FDA Clearance
The Discovery MR750w with Geometry Enhancing Method (GEM) suite of coils has a patient-friendly design and 70 cm bore to accommodate the hard-to-scan patients, such as larger, claustrophobic, elderly or very young patients, the company said.
GE Healthcare has received FDA 510(k) clearance of its 3-T wide bore MR system touted to provide a more comfortable scanning experience, the company announced today.
The Discovery MR750w with Geometry Enhancing Method (GEM) suite of coils has a patient-friendly design and 70 cm bore to accommodate the hard-to-scan patients, such as larger, claustrophobic, elderly or very young patients, the company said. The system includes a 50 x 50 x 50 cm field of view and enables reduced exam time and the ability to scan large anatomy with fewer scans, compared to older systems.
GE’s Optical RF (OpTix) provides high channel count, analog to digital-optical signal conversion inside the scan room, which the company said would minimize noise and signal degradation. GE’s RF coil design uses thinner, lightweight, flexible material that embraces the patient and allows for easier patient positioning. The GEM suite includes a high density GEM posterior array embedded in the table, a GEM head and neck unit with comfort tilt, the GEM anterior array, and the GEM peripheral vascular/lower extremity array. The GEM coils can be used individually or combined to provide complete coverage, the company said.
“Under that sleek exterior is some of the most advanced technology we’ve ever built into an MR,” Jacques Coumans, GE’s general manager for premium MR, said in a statement. “Our goal has been to deliver a 3.0T system with a 70cm bore with no compromises.”
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
